FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely radiology, and can be used to deliver a therapeutic dose for inhaled low-dose radionuclide therapy in patients with COVID-19. The radiation dose is administered by inhalation by the patient for 2 minutes of an ultrafine aerosol of carbon nanoparticles labeled with 99mTc, obtained by loading a sodium pertechnetate solution with a specific activity of at least 12 GBq into the crucible of the generator.
EFFECT: method provides the delivery of a therapeutic dose for low-dose radionuclide therapy due to the inhalation of the radiation dose.
1 cl, 1 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF EXAMINING THE STATE OF THE LUNGS WITH SUSPECTED COVID-19 USING LOW-DOSE COMPUTED TOMOGRAPHY | 2020 |
|
RU2744552C1 |
| LYOPHILIZATE FOR OBTAINING DIAGNOSTIC RADIOPHARMACEUTICAL DRUG BASED ON RADIONUCLIDE Tc | 2022 |
|
RU2799325C2 |
| METHOD OF TREATING INITIAL STAGES OF ORAL CANCER | 2019 |
|
RU2713940C1 |
| METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
| METHOD FOR DIAGNOSING DAMAGE TO THE RESPIRATORY SYSTEM BY METHODS OF RADIONUCLIDE INDICATION IN PATIENTS WITH CONNECTIVE TISSUE DYSPLASIA | 2021 |
|
RU2784840C1 |
| METHOD FOR DETERMINING INDIVIDUAL ACTIVITY OF 131-IODINE FOR RADIOIODINE THERAPY OF THYROTOXICOSIS AND PREDICTION OF TIME FOR ACHIEVING A SAFE LEVEL OF 131-IODINE ACTIVITY IN THE PATIENT'S BODY AFTER ADMINISTERING INDIVIDUAL 131-IODINE ACTIVITY | 2019 |
|
RU2722568C1 |
| METHOD FOR RADIONUCLIDE DIAGNOSTICS OF LUNG CANCER | 2020 |
|
RU2751103C1 |
| METHOD FOR TREATING PATIENTS WITH A NEW CORONAVIRUS INFECTION COVID-19 WITH HIGH-FLOW OXYGENATION | 2022 |
|
RU2787175C1 |
| METHOD OF QUANTITATIVE ASSESSMENT OF DEGREE OF CELLULAR PREPARATION RETENTION WITHIN TARGET ORGAN WHEN INTRAORGAN ADMINISTRATION USING RADIONUCLIDE METHOD | 2022 |
|
RU2809526C2 |
| METHOD OF TREATING ORAL CANCER | 2019 |
|
RU2713530C2 |
